Mitsubishi UFJ Trust & Banking Corp Sells 9,766 Shares of HCA Healthcare, Inc. $HCA

Mitsubishi UFJ Trust & Banking Corp decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 195,405 shares of the company’s stock after selling 9,766 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in HCA Healthcare were worth $74,860,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD boosted its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares during the period. Nuveen LLC purchased a new position in HCA Healthcare during the first quarter worth about $569,217,000. Pacer Advisors Inc. boosted its position in shares of HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the last quarter. Finally, Nordea Investment Management AB increased its position in shares of HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after purchasing an additional 59,163 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Truist Financial raised their price objective on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Oppenheimer boosted their target price on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Sanford C. Bernstein restated a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Finally, Mizuho lifted their price objective on HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $474.08 on Thursday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $479.43. The firm has a market cap of $108.18 billion, a price-to-earnings ratio of 18.33, a PEG ratio of 1.38 and a beta of 1.41. The company has a 50-day moving average of $431.29 and a 200 day moving average of $394.54.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the prior year, the company posted $4.90 earnings per share. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.